|
Market Closed -
Australian S.E.
08:10:09 20/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.5900 AUD | -2.48% |
|
+2.61% | -34.81% |
| 11-20 | Healius Gets ACCC Approval for Sale of Agilex Biolabs to Novotech | MT |
| 10-23 | Proteomics International Laboratories Set to Start National Rollout of Two Blood Tests | MT |
| Market Cap | 428M 285M 259M 239M 217M 408M 26.36B 2.91B 1.16B 14.4B 1.07B 1.05B 45.18B | P/E 2027 * |
109x | P/E 2028 * | -125x |
|---|---|---|---|---|---|
| Enterprise Value | 1.21B 801M 729M 672M 611M 1.15B 74.15B 8.18B 3.25B 40.5B 3B 2.94B 127B | EV / Sales 2027 * |
0.87x | EV / Sales 2028 * | 0.85x |
| Free-Float |
75% | Yield 2027 * |
-
| Yield 2028 * | 1.33% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| HLS | Delayed | |
| PGZ | Delayed | ||
| PGZ | Delayed |
Last Transcript: Healius Limited
| 1 day | -2.48% | ||
| 1 week | +2.61% | ||
| Current month | +19.19% | ||
| 1 month | +51.28% | ||
| 3 months | +26.88% | ||
| 6 months | +71.01% | ||
| Current year | -34.81% |
| 1 week | 0.57 | 0.62 | |
| 1 month | 0.39 | 0.62 | |
| Current year | 0.3 | 1.05 | |
| 1 year | 0.3 | 1.07 | |
| 3 years | 0.3 | 1.86 | |
| 5 years | 0.3 | 5.54 | |
| 10 years | 0.3 | 5.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Anderson
CEO | Chief Executive Officer | - | 05/03/2024 |
Andrew Thomson
DFI | Director of Finance/CFO | - | 13/10/2025 |
Renu Vohra
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Evans
BRD | Director/Board Member | - | 21/08/2018 |
Kathryn McKenzie
CHM | Chairman | 65 | 28/11/2023 |
Paul Anderson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/27/26 A | Buy | Chief Executive Officer | 117,433 | 0.0162% | ||
| 10/26/26 A | Buy | Director | 35,000 | 0.0048% | ||
| 10/23/26 A | Buy | Chief Executive Officer | 232,941 | 0.0321% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.48% | +2.61% | -37.23% | -67.85% | 285M | ||
| +1.00% | -9.52% | +6.31% | +18.43% | 103B | ||
| +3.31% | -4.70% | -0.15% | +91.45% | 99.34B | ||
| -5.70% | -14.32% | +21.21% | +399.00% | 39.62B | ||
| -0.73% | -0.48% | +14.07% | +94.82% | 31.77B | ||
| -0.47% | -0.90% | +40.41% | +73.91% | 29.81B | ||
| -0.31% | -0.51% | +37.67% | +91.53% | 28.42B | ||
| -0.15% | -7.99% | +40.98% | +305.22% | 20.95B | ||
| -0.62% | -2.67% | -15.69% | -20.65% | 19.39B | ||
| 0.00% | -0.38% | -2.83% | +32.77% | 16.97B | ||
| Average | -0.62% | -3.83% | +10.48% | +101.86% | 39B | |
| Weighted average by Cap. | +0.37% | -5.85% | +12.04% | +105.51% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.39B 921M 839M 773M 703M 1.32B 85.32B 9.41B 3.74B 46.6B 3.46B 3.38B 146B | 1.41B 940M 856M 789M 718M 1.35B 87.03B 9.6B 3.82B 47.54B 3.53B 3.45B 149B |
| Net income | -2.77M -1.84M -1.67M -1.54M -1.4M -2.63M -170M -18.77M -7.46M -92.93M -6.89M -6.75M -292M | -4.35M -2.89M -2.63M -2.42M -2.2M -4.13M -267M -29.49M -11.72M -146M -10.83M -10.6M -458M |
| Net Debt | 777M 516M 470M 433M 394M 739M 47.79B 5.27B 2.1B 26.1B 1.94B 1.9B 81.92B | 776M 516M 470M 433M 394M 739M 47.77B 5.27B 2.09B 26.09B 1.94B 1.89B 81.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | A$0.5900 | -2.48% | 2,036,181 |
| 19/11/26 | A$0.6050 | +4.31% | 6,477,376 |
| 18/11/26 | A$0.5800 | -3.33% | 1,088,688 |
| 17/11/26 | A$0.6000 | +3.45% | 6,740,450 |
| 16/11/26 | A$0.5800 | +0.87% | 9,657,591 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
















